The Spencer Dayman Laboratories acquires a Qubit Flex Flourometer

The Qubit Flex Flourometer will greatly enhance our ongoing Group A Strep study.


The Spencer Dayman Laboratories have recently acquired a Qubit Flex Flourometer to enhance our ongoing Group A Strep study. This cutting-edge instrument offers the capability to rapidly and precisely measure the quantities of DNA, RNA, protein, and endotoxin in up to eight samples concurrently. This advanced technology significantly expedites the process while ensuring accurate results. We extend our deepest gratitude to the Kilpatrick Fraser Charitable Trust for their generous grant, which made this acquisition possible. The Qubit Flex Flourometer will undoubtedly enhance our research capabilities and contribute to the successful advancement of our Group A Strep study.

Photo: Dr Anu Goenka, Dr Alice Halliday and Steve Dayman.

News and Stories

Let us know if you’re considering organising an event.

Make a donation and know that 100% will go towards our research


The Research Goes On

To get involved or share your experience please get in touch or connect with us on social.

Press enter to search or esc to cancel